Furthermore, in our study, patients with polycythemia were younger, had a better nutritional status (higher BMI and albumin), lower inflammatory markers (CRP, PCT, G test, GM test), which might also be one of the reasons why they had a lower risk of adverse outcomes. The gene discussed is ALB; the disease is polycythemia.